Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Greene TD et al. - Pain after SWL is moderate to severe using third-generation lithotriptors and is significantly reduced by POD 3. Younger patients and those with significant pretreatment pain had more pain after treatment. Preemptive Rofecoxib reduced post-SWL pain, but had no impact on stone passage. This article contributes greatly to our understanding of pain with SWL. First, it quantifies the natural progression of pain after SWL - moderate-severe (5 or 10) for the first 2 days, subsiding almost completely by Day 7. Secondly, it identifies patients with a higher risk of significant pain post-operative - younger patients, and those with pre-SWL pain. These subsets would warrant further investigation in the future to identify effective adjuvant analgesic approaches.

Related Articles

NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib
Pharmacoepidemiology and Drug Safety, 10/27/09    Relevance Score: 84%

Today in Stone Disease...keeping you current

Extracorporeal shock-wave lithotripsy and garlic consumption: a lesson to learn
Urological Research - Urolithiasis, 12/18/09

Outcome of Percutaneous Nephrolithotomy in Children Having Complex Stones
Urologia Internationalis, 12/17/09

Cost-Effectiveness of Treating Ureteral Stones in a Taipei City Hospital: Shock Wave Lithotripsy versus Ureteroscopy plus Lithoclast
Urologia Internationalis, 12/17/09